Retinal Vein Occlusion

"Retinal Vein Occlusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES.

Descriptor ID	D012170
MeSH Number(s)	C11.768.760 C14.907.355.830.925.650 C14.907.760
Concept/Terms	Retinal Vein Occlusion Retinal Vein Occlusion Occlusion, Retinal Vein Occlusions, Retinal Vein Retinal Vein Occlusions Vein Occlusion, Retinal Vein Occlusions, Retinal Retinal Vein Thrombosis Retinal Vein Thrombosis Retinal Vein Thromboses Thromboses, Retinal Vein Vein Thromboses, Retinal Vein Thrombosis, Retinal Thrombosis, Retinal Vein

Below are MeSH descriptors whose meaning is more general than "Retinal Vein Occlusion".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Retinal Vein Occlusion [C11.768.760]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Embolism and Thrombosis [C14.907.355]
Thrombosis [C14.907.355.830]
Venous Thrombosis [C14.907.355.830.925]
Retinal Vein Occlusion [C14.907.355.830.925.650]
Retinal Vein Occlusion [C14.907.760]

Below are MeSH descriptors whose meaning is related to "Retinal Vein Occlusion".

Below are MeSH descriptors whose meaning is more specific than "Retinal Vein Occlusion".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Retinal Vein Occlusion" by people in this website by year, and whether "Retinal Vein Occlusion" was a major or minor topic of these publications.

Bar chart showing 78 publications over 25 distinct years, with a maximum of 9 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	0	1	1
1998	1	0	1
2000	1	0	1
2001	1	0	1
2002	1	0	1
2003	2	1	3
2005	1	1	2
2006	1	0	1
2007	3	0	3
2008	1	1	2
2010	2	0	2
2011	3	1	4
2012	4	0	4
2014	7	0	7
2015	7	2	9
2016	4	0	4
2017	5	0	5
2018	5	1	6
2019	4	0	4
2020	4	1	5
2021	6	0	6
2022	3	0	3
2023	1	0	1
2024	1	0	1

Below are the most recent publications written about "Retinal Vein Occlusion" by people in Profiles.

Cullhed Farrell A, Epstein D. RETINAL VEIN OCCLUSIONS BEFORE AND DURING THE COVID-19 PANDEMIC: Visual Outcomes and Treatment Patterns in a Country with no Mandatory Lockdown. Retina. 2024 Jun 01; 44(6):1045-1051.

View in: PubMed
Wai KM, Ludwig CA, Koo E, Parikh R, Mruthyunjaya P, Rahimy E. Risk of Stroke, Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Death After Retinal Vein Occlusion. Am J Ophthalmol. 2024 01; 257:129-136.

View in: PubMed
Ponder CM, Rather PA, Soliman MK, Jabbehdari S, Neuhouser A, Siddiqui MZ, Yang YC, Sallam AB. Intraoperative complications and visual outcomes of cataract surgery in patients with retinal vein occlusion: multicenter database study. J Cataract Refract Surg. 2022 06 01; 48(6):697-704.

View in: PubMed
Ashkenazy N, Patel NA, Sridhar J, Yannuzzi NA, Belin PJ, Kaplan R, Kothari N, Benitez Bajandas GA, Kohly RP, Roizenblatt R, Pinhas A, Mundae R, Rosen RB, Ryan EH, Chiang A, Chang LK, Khurana RN, Finn AP. Hemi- and Central Retinal Vein Occlusion Associated with COVID-19 Infection in Young Patients without Known Risk Factors. Ophthalmol Retina. 2022 06; 6(6):520-530.

View in: PubMed
Thangamathesvaran L, Miller SC, Tsou B, Fliotsos MJ, Yonekawa Y, Chen A, Hoskin AK, Blanch RJ, Cavuoto K, Meeralakshmi P, Low R, Gardiner M, Alvin Liu TY, Agrawal R, Justin GA, Woreta FA. Global Current Practice Patterns for the Management of Central Retinal Artery Occlusion. Ophthalmol Retina. 2022 05; 6(5):429-431.

View in: PubMed
Nanji K, Khan M, Khalid MF, Xie JS, Sarohia GS, Phillips M, Thabane L, Garg SJ, Kaiser P, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis. Acta Ophthalmol. 2022 Sep; 100(6):e1199-e1208.

View in: PubMed
Salabati M, Mahmoudzadeh R, Wong JC, Patel D, Patel SN, Obeid A, Sivalingam A, Vander JF, Garg SJ, Ho AC, Regillo CD, Hsu J. Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy. Br J Ophthalmol. 2022 12; 106(12):1742-1747.

View in: PubMed
Li Y, Hall NE, Pershing S, Hyman L, Haller JA, Lee AY, Lee CS, Chiang M, Lum F, Miller JW, Lorch A, Elze T. Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS? Registry. Ophthalmol Retina. 2022 02; 6(2):161-171.

View in: PubMed
Obeid A, Hsu J, Ehmann D, Gao X, Sridhar J, Chiang A, Park CH, Ho AC. TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDY. Retin Cases Brief Rep. 2021 Mar 01; 15(2):120-126.

View in: PubMed
Wai KM, Vingopoulos F, Garg I, Kasetty M, Silverman RF, Katz R, La?ns I, Miller JW, Husain D, Vavvas DG, Kim LA, Miller JB. Contrast sensitivity function in patients with macular disease and good visual acuity. Br J Ophthalmol. 2022 06; 106(6):839-844.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement